MetaCap

Abeona Therapeutics Statistics

NASDAQ: ABEOHealth CareBiotechnology: Pharmaceutical PreparationsUSD

2.42-0.03 (-1.22%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Abeona Therapeutics by the numbers

Abeona Therapeutics has a market capitalization of $165.3 million based on 68.31M shares outstanding. With trailing EPS of $-1.16, Abeona Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 44.8% below its 50-day average and 54.6% below its 200-day average.

Average daily trading volume is 1.66M shares, or about $4.0 million in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

ABEO valuation vs. peer median

ABEO compared with the median of 8 peer companies
MetricABEOPeer medianDifference
Market cap$165.31M$171.38M-4%
Avg. volume1.66M179.70K+822%

Peer median across 8 companies: KRRO, TRDA, EMIS, SIGA, VOGX, NATR, ORMP, ADCT.

Valuation

Market cap
$165.31M
Price / sales (latest FY)
28.40
EPS (TTM)
$-1.16

Price and trading

Previous close
2.45
Open
2.43
Day range
2.40 – 2.57
52-week range
2.09 – 7.65
52-week change
-45.98%
Beta
—
Volume
4.72M

Dividends and events

Annual dividend
None

Additional statistics

Market Cap
165.31M
Forward Pe
-5.02
Eps
-1.16
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
7.65
Week52 Low
2.09
Avg Volume
1.66M
Shares Outstanding
68.31M
Ma50
4.38
Ma200
5.33
Earnings Date
Nov 9, 2026
Pct From52w High
-68.37%
Pct From52w Low
15.79%

Related